Abstract
Relapsing polychondritis is a rare autoimmune inflammatory syndrome with no established treatment guidelines or placebo-controlled clinical trials. Most treatment plans are based on anecdotal case reports. We present a case of refractory relapsing polychondritis in a patient with Crohn’s disease. She has responded well and has achieved clinical remission on treatment with interleukin-6 receptor inhibitor tocilizumab.
Similar content being viewed by others
Data Availability
All authors had access to the data and materials.
Code Availability
Not applicable.
References
Haslag-Minoff J, Regunath H. Relapsing polychondritis. N Engl J Med. 2018;378:1715.
Mathian A, Miyara M, Cohen-Aubart F, et al. Relapsing polychondritis: A 2016 update on clinical features, diagnostic tools, treatment and biological drug use. Best Pract Res Clin Rheumatol. 2016;30:316–33.
Chopra R, Chaudhary N, Kay J. Relapsing Polychondritis. Rheum Dis Clin N Am. 2013;39:263–76.
Puechal X, Terrier B, Mouthon L, Costedoat-Chalumeau N, Guillevin L, Le Jeunne C. Relapsing polychondritis. Joint Bone Spine. 2014;81:118–24.
Sharma A, Gnanapandithan K, Sharma K, Sharma S. Relapsing polychondritis: a review. Clin Rheumatol. 2013;32:1575–83.
Trentham DE, Le CH. Relapsing Polychondritis. Ann Intern Med. 1998;129:114–22.
McAdam LP, O’Hanlan MA, Bluestone R, Pearson CM. Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine (Baltimore). 1976;55(3):193–215.
Kemta Lekpa F, Kraus VB, Chevalier X. Biologics in relapsing polychondritis: a literature review. Semin Arthritis Rheum. 2012;41:712–9.
Moulis G, Sailler L, Pugnet G, Astudillo L, Arlet P. Biologics in relapsing polychondritis: a case series. Clin Exp Rheumatol. 2013;31:937–9.
Stael R, Smith V, Wittoek R, Creytens D, Mielants H. Sustained response to tocilizumab in a patient with relapsing polychondritis with aortic involvement: a case based review. Clin Rheumatol. 2015;34:189–93.
Vitale A, Sota J, Rigante D, et al. Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives. Curr Rheumatol Rep. 2016;18:3.
Gabay C. Interleukin-6 and chronic inflammation. Arthritis Res Ther. 2006;8(Suppl 2):S3. https://doi.org/10.1186/ar1917.
Thorne IC, Jawad ASM, Sutcliffe N. Refractory relapsing polychondritis, responsive to IL-6 blockade. Grand Rounds. 2015;15:1–3.
Author information
Authors and Affiliations
Contributions
All authors had a role in the creation of this manuscript. Both authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics Approval
Not applicable.
Consent to Participate
Not applicable.
Consent for Publication
The patient featured in this case report has given written consent for the case to be published.
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Medicine
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Moy, L.N., Brandwein, S.R. Case Report: Successful Treatment of Relapsing Polychondritis and Crohn’s Disease with Tocilizumab. SN Compr. Clin. Med. 4, 226 (2022). https://doi.org/10.1007/s42399-022-01310-1
Accepted:
Published:
DOI: https://doi.org/10.1007/s42399-022-01310-1